Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Feb 25

PMID 36834734

Authors

Yujiao Zeng

Yuting Luo

Lijie Wang

Kun Zhang

Jiayan Peng

Gang Fan

Affiliations

Soon will be listed here.

Abstract

Metabolic diseases have become a serious threat to human health worldwide. It is crucial to look for effective drugs from natural products to treat metabolic diseases. Curcumin, a natural polyphenolic compound, is mainly obtained from the rhizomes of the genus . In recent years, clinical trials using curcumin for the treatment of metabolic diseases have been increasing. In this review, we provide a timely and comprehensive summary of the clinical progress of curcumin in the treatment of three metabolic diseases, namely type 2 diabetes mellitus (T2DM), obesity and non-alcoholic fatty liver disease (NAFLD). The therapeutic effects and underlying mechanisms of curcumin on these three diseases are presented categorically. Accumulating clinical evidence demonstrates that curcumin has good therapeutic potential and a low number of side effects for the three metabolic diseases. It can lower blood glucose and lipid levels, improve insulin resistance and reduce inflammation and oxidative stress. Overall, curcumin may be an effective drug for the treatment of T2DM, obesity and NAFLD. However, more high-quality clinical trials are still required in the future to verify its efficacy and determine its molecular mechanisms and targets.

Citing Articles

Impacts of Curcumin Supplementation on Cardiometabolic Risk Factors in Patients With Polycystic Ovary Syndrome: A Systematic Review and Dose-Response Meta-Analysis.

Mohammadi S, Ziaei S, Morvaridi M, Hasani M, Mirtaheri E, Farsi F Health Sci Rep. 2025; 8(3):e70525.

PMID: 40041784 PMC: 11872691. DOI: 10.1002/hsr2.70525.

Exploring the role of curcumin in mitigating oxidative stress to alleviate lipid metabolism disorders.

Cheng M, Ding F, Li L, Dai C, Sun X, Xu J Front Pharmacol. 2025; 16:1517174.

PMID: 39950117 PMC: 11822302. DOI: 10.3389/fphar.2025.1517174.

Bird's eye view of natural products for the development of new anti-HIV agents: Understanding from a therapeutic viewpoint.

Al Amin M, Nafady M, Zehravi M, Sweilam S, Kumar K, Akiful Haque M Animal Model Exp Med. 2025; 8(3):441-457.

PMID: 39921221 PMC: 11904116. DOI: 10.1002/ame2.12563.

Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs.

Wan X, Ma J, Bai H, Hu X, Ma Y, Zhao M Biomolecules. 2025; 15(1).

PMID: 39858534 PMC: 11764138. DOI: 10.3390/biom15010140.

Soothing the Itch: The Role of Medicinal Plants in Alleviating Pruritus in Palliative Care.

Goncalves S, Fernandes L, Caramelo A, Martins M, Rodrigues T, Matos R Plants (Basel). 2025; 13(24.

PMID: 39771213 PMC: 11677410. DOI: 10.3390/plants13243515.

References

Mohammadi A, Sahebkar A, Iranshahi M, Amini M, Khojasteh R, Ghayour-Mobarhan M . Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytother Res. 2012; 27(3):374-9. DOI: 10.1002/ptr.4715. View

Cai L, Liu S, Sun L, Wang Y, Ji H, Li J . Application of tea polyphenols in combination with 6-gingerol on shrimp paste of during storage: biogenic amines formation and quality determination. Front Microbiol. 2015; 6:981. PMC: 4584979. DOI: 10.3389/fmicb.2015.00981. View

Rehman K, Akash M . Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?. J Biomed Sci. 2016; 23(1):87. PMC: 5135788. DOI: 10.1186/s12929-016-0303-y. View

Yu M, Tong H, Mao C, Su D, Yin F, Fei C . [Study on quality identification of Curcumae Rhizoma from different origins based on quantitative analysis of appearance color and content of main components]. Zhongguo Zhong Yao Za Zhi. 2021; 46(6):1393-1400. DOI: 10.19540/j.cnki.cjcmm.20201111.301. View

Shafabakhsh R, Mobini M, Raygan F, Aghadavod E, Ostadmohammadi V, Amirani E . Curcumin administration and the effects on psychological status and markers of inflammation and oxidative damage in patients with type 2 diabetes and coronary heart disease. Clin Nutr ESPEN. 2020; 40:77-82. DOI: 10.1016/j.clnesp.2020.09.029. View

Hariri M, Gholami A, Mirhafez S, Bidkhori M, Sahebkar A . A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial. Complement Ther Med. 2020; 51:102447. DOI: 10.1016/j.ctim.2020.102447. View

Saadati S, Hatami B, Yari Z, Shahrbaf M, Eghtesad S, Mansour A . The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease. Eur J Clin Nutr. 2019; 73(3):441-449. DOI: 10.1038/s41430-018-0382-9. View

Williamson R, Price J, Glancy S, Perry E, Nee L, Hayes P . Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care. 2011; 34(5):1139-44. PMC: 3114489. DOI: 10.2337/dc10-2229. View

Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A . Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial. Phytother Res. 2016; 30(9):1540-8. DOI: 10.1002/ptr.5659. View

10.

Wang X, Wang Y, Antony V, Sun H, Liang G . Metabolism-Associated Molecular Patterns (MAMPs). Trends Endocrinol Metab. 2020; 31(10):712-724. DOI: 10.1016/j.tem.2020.07.001. View

11.

Lou Y, Zheng J, Hu H, Lee J, Zeng S . Application of ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry to identify curcumin metabolites produced by human intestinal bacteria. J Chromatogr B Analyt Technol Biomed Life Sci. 2015; 985:38-47. DOI: 10.1016/j.jchromb.2015.01.014. View

12.

Saberi-Karimian M, Keshvari M, Ghayour-Mobarhan M, Salehizadeh L, Rahmani S, Behnam B . Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial. Complement Ther Med. 2020; 49:102322. DOI: 10.1016/j.ctim.2020.102322. View

13.

Panahi Y, Khalili N, Sahebi E, Namazi S, Saberi Karimian M, Majeed M . Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial. Inflammopharmacology. 2016; 25(1):25-31. DOI: 10.1007/s10787-016-0301-4. View

14.

Ramkumar S, Raghunath A, Raghunath S . Statin Therapy: Review of Safety and Potential Side Effects. Acta Cardiol Sin. 2016; 32(6):631-639. PMC: 5126440. DOI: 10.6515/acs20160611a. View

15.

Muoio D . Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock. Cell. 2014; 159(6):1253-62. PMC: 4765362. DOI: 10.1016/j.cell.2014.11.034. View

16.

Giordano A, Tommonaro G . Curcumin and Cancer. Nutrients. 2019; 11(10). PMC: 6835707. DOI: 10.3390/nu11102376. View

17.

Usharani P, Mateen A, Naidu M, Raju Y, Chandra N . Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. Drugs R D. 2008; 9(4):243-50. DOI: 10.2165/00126839-200809040-00004. View

18.

Wang G, Hoyte C . Review of Biguanide (Metformin) Toxicity. J Intensive Care Med. 2018; 34(11-12):863-876. DOI: 10.1177/0885066618793385. View

19.

Al-Mrabeh A . β-Cell Dysfunction, Hepatic Lipid Metabolism, and Cardiovascular Health in Type 2 Diabetes: New Directions of Research and Novel Therapeutic Strategies. Biomedicines. 2021; 9(2). PMC: 7927138. DOI: 10.3390/biomedicines9020226. View

20.

Liu C, Li L, Guo D, Lv Y, Zheng X, Mo Z . Lipoprotein lipase transporter GPIHBP1 and triglyceride-rich lipoprotein metabolism. Clin Chim Acta. 2018; 487:33-40. DOI: 10.1016/j.cca.2018.09.020. View